MBX Biosciences, Inc. Common Stock ( MBX) - Stock Earnings
MBX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
MBX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -22.1 million USD | — USD |
| 2026Q1 | -23.5 million USD | — USD |
| 2026Q2 | -37.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MBX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -32.6 million USD | — USD |
| 2024 | -61.9 million USD | — USD |
| 2025 | -87.0 million USD | — USD |
| 2026 Est. | — | — |
MBX
Price: $50.71
52 week price:
Earnings Per Share: 7.67 USD
P/E Ratio: 4.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.7 billion